Single-payer healthcare: What the US can learn from Canada’s healthcare system

Advertisement

Few policy debates generate as much passion — or as many misconceptions — as the question of whether the U.S. should replace its siloed healthcare system with a single-payer model. While there is much to discuss around single payer, one point on which we can all agree is that the country  spends far too much on healthcare for the outcomes we achieve.  

Over time, the cost of delivering care has increased across nearly every part of the healthcare ecosystem, from supplies, drugs and equipment to administrative processes and labor. At the same time, the fee-for-service model can reward more care instead of better care. Together, these forces have created a system in which costs continue to rise without a consistent improvement in outcomes. 

Health economists define a functioning healthcare system by these three pillars: cost, quality, and access. Together, they form what is sometimes called the “Iron Triangle.” The system is most stable when all three are working together, but improving one side can put pressure on and weaken the others.

Over the past 80 years, the U.S. has pursued reforms aimed at improving one or more sides of this triangle. The Hill-Burton Act expanded hospital construction in rural and underserved areas. Medicare and Medicaid extended coverage to seniors and low-income Americans. The Affordable Care Act helped reduce the number of uninsured people.

Each of these reforms made important contributions. Yet the country still faces high prices, uneven access, gaps in insurance coverage and outcomes that do not align with our level of spending. These reforms were layered onto a system that still largely rewards volume over value. As a result, expanding coverage has not been enough to address the underlying cost and quality problems.

That brings us to the question that increasingly arises in the U.S.: Would a national, single-payer model produce better results? 

I’ve worked in the U.S. healthcare system for more than 35 years and had the opportunity to study health systems on the ground with clinicians, patients and government leaders in Canada, the United Kingdom, Sweden, Eastern Europe, Hong Kong, India and the South Pacific.

That experience has reinforced an important lesson: no health system eliminates trade-offs. The real question is which trade-offs are we willing to tolerate?

Canada offers an important comparison

As healthcare prices become increasingly untenable, there is growing interest in some form of single payer in the U.S. Public support often increases when people are asked about a national health plan in general terms, but it declines when they are asked to consider the details that accompany this model, including changes to or the elimination of private insurance, increased taxes and treatment delays.

Canada is frequently cited as the most obvious example of what a single-payer system could look like and indeed is a strong comparison, but it should be viewed as an instructive example, not a template that we can copy. Focusing on Canada — compared to other nation’s systems — makes sense as Canada most closely resembles the racial and cultural heterogeneity of the U.S.  This is important as there is substantial evidence across health economics, sociology and public health that population heterogeneity creates measurable political, operational and clinical challenges for health systems. 

Canada spends less on healthcare as a share of its economy — approximately 11% of GDP compared with approximately 17% in the United States. It also provides core health insurance coverage to essentially its entire population, compared with 90% in the U.S.

The Canadian system also provides publicly funded coverage for medically necessary physician services, hospital care, diagnostic testing, preventive care and medications administered in a hospital. It generally does not cover outpatient prescription drugs, routine dental care, vision care, ambulance services, medical devices or cosmetic surgery.

That means a nationally financed system does not necessarily mean that every healthcare need is covered. Two-thirds of Canadians carry private supplemental insurance — often through an employer or purchased individually — to pay for services outside the public plan.

The system also relies on taxes to finance public coverage. The trade-off is not that Canadians pay nothing for healthcare, but they pay through a different combination of taxes, supplemental insurance and out-of-pocket expenses. Canada’s lower national spending is real. So are the questions about access and capacity.

Cost savings can create other pressures

One of the most discussed aspects of the Canadian system are wait times. Compared with the U.S., Canadians can face substantially longer wait times. Wait time for a new patient’s family medicine visits in Canada spans from six months to more than two years, while in the U.S. it’s 3.4 weeks. For specialist treatment, the average wait time in Canada is 40-50 weeks while in the U.S. it’s 1-4 weeks, and for diagnostic imaging, it’s 9-18 weeks in Canada compared to 1-3 weeks in the U.S.

That is not an argument against changing how healthcare is financed, but it is a trade-off that deserves acknowledgment.

If the U.S. were to move toward a national financing model, it would also need to expand primary care, specialty care, diagnostic capacity, surgical capacity and the workforce required to deliver that care. Otherwise, the country could reduce spending in one part of the system while creating new bottlenecks for patients in another.

Canada’s experience also raises a broader question about capacity. A commonly cited observation is that Canada’s system operates within a North American healthcare ecosystem that includes access to the advanced specialty services in the U.S.

If the U.S. adopted similar constraints, it would not have an equivalent neighboring system to absorb demand. Again, that is not an argument for preserving the status quo. It’s an argument for recognizing that financing and delivery-system reform must happen together.

What should the U.S. pursue?

The U.S. should pursue a better model that reduces costs without sacrificing quality or access. That means investing in more primary and specialty care, and incentivizing prevention and coordinated care while increasing price transparency and accountability amongst health systems, health plans and pharmaceutical companies.

The goal should be to learn from every system, including Canada, while building an approach that reflects the size, geography, diversity, clinical capacity and economic realities of the U.S.

The right question is not whether the U.S. can spend less. It’s whether we can spend less while delivering better outcomes and access. Any reform must account for all three sides of the triangle: cost, quality, and access. The standard should be the right care, in the right place, at the right time, at a cost patients, employers and the country can sustain.

Advertisement

Next Up in Financial Management

Advertisement